N-Nitroso Binimetinib
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Binimetinib treats melanoma by stopping cancer cells from growing. Melanoma is an invasive form of skin cancer. This medication comes as a tablet that you can take by mouth with a glass of water as directed.N-Nitroso Binimetinib is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Binimetinib CAS NO:NA chemically represented as 5-((4-Bromo-2-fluorophenyl)(nitroso)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide. Synchemia is the leading manufacturing and exporter of N-Nitroso Binimetinib . We supply N-Nitroso Binimetinib with detailed characterization data compliance with regulatory guidelines.